B Cell Production
B Cell Production - Related Videos
08:15
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
0 Views •
Cited by 11 •
2018
A detailed protocol for the concurrent operation of 48 parallel cell cultures under varied conditions in a microbioreactor system is presented. Cell culture process, harvest and subsequent antibody titer analysis are described.
08:46
Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
0 Views •
Cited by 44 •
2012
In this protocol we describe production, purification and titration of lentiviral vectors. We provide an example of lentiviral vector-mediated gene delivery in primary cultured neurons and astrocytes. Our methods may also apply to other cell types in vitro and in vivo.
03:37
Handling Neuronal Stem Cell Cultures in a Cell Production Facility
0 Views •
2025
The video outlines the procedure for maintaining a controlled environment in a cell culture workstation for the growth and maintenance of neuronal stem cells. These procedures involve setting chamber conditions, cleaning protocols, and media preparation, Thus, maintaining maximum sterility and reproducibility and replacing the traditional methods.
09:41
A Method For Production of Recombinant mCD1d Protein in Insect Cells.
0 Views •
Cited by 3 •
2007
A Method to prepare Insect cells and infect them with baculovirus for the the purpose of production of recombinant mCD1d proteinand generating mCD1d tetramers.
09:19
Recombinant Retroviral Production and Infection of B Cells
0 Views •
Cited by 2 •
2011
An efficient system of structure and function analysis of a gene in an ex vivo culture of splenic B-lymphocytes is described. This method takes advantage of recombinant retroviral production in a helper free, ecotrophic packaging cell line. Stable, heritable expression of a gene of interest within primary lymphocytes is achieved leading to generation of surface antibodies on B cells undergoing class switch recombination.
FAQs
During development in the bone marrow, precursor cells undergo V(D)J gene rearrangement to assemble distinct B cell receptor configurations. This process gives individual B lymphocytes unique receptor specificities rather than identical recognition patterns. The resulting diversity allows the developing immune system to generate a broad population of B cells capable of responding to different antigens.
Selection limits the release of developing B cells whose receptors strongly recognize self. Cells with such receptors may be removed, while some can revise their receptor configuration. This quality-control step helps shape a B cell population that is less likely to direct antibody-mediated responses against the body's own components, linking receptor generation with immune tolerance.
The bone marrow supports sequential differentiation, receptor rearrangement, and selection of developing B cells. After maturation, naïve B cells migrate to peripheral lymphoid organs, where they encounter antigen and receive appropriate signaling. These locations therefore support distinct stages: early generation and screening in marrow, followed by mature-cell positioning and possible immune activation elsewhere.
After a mature naïve B cell recognizes antigen with appropriate signaling, its subsequent differentiation can produce either an antibody-secreting plasma cell or a long-lived memory cell. Plasma cells provide the immediate antibody-producing outcome, whereas memory cells preserve a durable population for future immune responses. The overview identifies these as major post-activation fates.
A study can follow the process from hematopoietic stem cells through precursor differentiation, receptor rearrangement, and selection in the bone marrow. Researchers can then examine migration of mature naïve cells to peripheral lymphoid organs and their response to antigen and signaling. This sequence connects cellular development with later formation of plasma and memory cells.
Vaccination research can use this biological framework to examine how antigen recognition and appropriate signaling influence mature B cells after they leave the bone marrow. The resulting plasma-cell and memory-cell pathways are especially relevant to antibody-mediated defense and longer-lasting immune responses. Thus, studying production connects early lymphocyte development with the outcomes sought in vaccination.
B cell production provides a framework for investigating problems at different stages of immune development. Disrupted generation or maturation can inform immunodeficiency research, inadequate control of self-reactive receptors relates to autoimmunity, and abnormal B cell development is relevant to B cell malignancies. The same developmental sequence therefore helps compare failures of quantity, tolerance, or cellular regulation.